Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
86 hedge funds and large institutions have $99.4M invested in Anthera Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 12 closing their positions.
59% more call options, than puts
Call options by funds: $2.33M | Put options by funds: $1.47M
57% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 21
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding
Funds holding: 86 → 86 (0)
22% less capital invested
Capital invested by funds: $128M → $99.4M (-$28.7M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$2.88M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.84M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.8M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$902K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$682K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.23M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.8M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.17M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$957K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$917K |
ANTH Hedge Fund Activity: Q4 2015 in Review
86 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q4 2015, worth a combined $99.4M — down 22% from $128M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ANTH positions and 12 closed out — a net gain of 1 holder — while 33 added to existing stakes and 21 trimmed.
The largest buyer was Sio Capital Management, adding an estimated $2.88M. The largest seller was Bogle Investment Management, cutting an estimated $3.23M.
- 86 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $99.4M of Anthera Pharmaceuticals, Inc. stock for Q4 2015, down 22% quarter-over-quarter.
- 13 funds opened new Anthera Pharmaceuticals, Inc. positions in Q4 2015 and 12 closed out, a net change of +1 holder.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q4 2015 was Sio Capital Management, an estimated $2.88M added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q4 2015 was Bogle Investment Management, an estimated $3.23M sold.
Based on aggregated 13F filings for Q4 2015.